Two Sigma Investments, LP Alaunos Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.04 - $0.13 $308 - $1,001	-7,700 Reduced 2.49%	301,517 $21,000
Q3 2023 Nov 14, 2023	SELL	$0.12 - $0.5 $12,896 - $53,736	-107,473 Reduced 25.79%	309,217 $40,000
Q2 2023 Aug 14, 2023	SELL	$0.43 - $0.65 $242,636 - $366,775	-564,270 Reduced 57.52%	416,690 $212,000
Q1 2023 May 15, 2023	SELL	$0.46 - $0.81 $301,696 - $531,249	-655,863 Reduced 40.07%	980,960 $618,000
Q4 2022 Feb 14, 2023	BUY	$0.5 - $261.0 $604,957 - $316 Million	1,209,914 Added 283.41%	1,636,823 $1.06 Million
Q3 2022 Nov 14, 2022	SELL	$1.04 - $322.5 $35,207 - $10.9 Million	-33,853 Reduced 7.35%	426,909 $734,000
Q2 2022 Aug 15, 2022	SELL	$0.41 - $1.24 $541,960 - $1.64 Million	-1,321,856 Reduced 74.15%	460,762 $571,000
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $525,551 - $991,766	-847,664 Reduced 32.23%	1,782,618 $1.16 Million
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $2.37 Million - $4.11 Million	2,174,715 Added 477.36%	2,630,282 $2.87 Million
Q3 2021 Nov 15, 2021	SELL	$1.44 - $2.73 $531,745 - $1.01 Million	-369,268 Reduced 44.77%	455,567 $829,000
Q2 2021 Aug 16, 2021	SELL	$2.63 - $3.67 $383,046 - $534,517	-145,645 Reduced 15.01%	824,835 $2.18 Million
Q1 2021 May 17, 2021	BUY	$2.82 - $5.6 $323,281 - $641,978	114,639 Added 13.39%	970,480 $3.49 Million
Q4 2020 Feb 16, 2021	BUY	$2.09 - $3.09 $184,530 - $272,822	88,292 Added 11.5%	855,841 $2.16 Million
Q3 2020 Nov 16, 2020	BUY	$2.39 - $3.43 $1.79 Million - $2.57 Million	750,688 Added 4452.22%	767,549 $1.93 Million
Q2 2020 Aug 14, 2020	SELL	$2.2 - $3.71 $946,858 - $1.6 Million	-430,390 Reduced 96.23%	16,861 $55,000
Q1 2020 May 15, 2020	BUY	$1.9 - $4.98 $607,473 - $1.59 Million	319,723 Added 250.71%	447,251 $1.1 Million
Q4 2019 Feb 14, 2020	BUY	$3.95 - $5.35 $85,999 - $116,480	21,772 Added 20.59%	127,528 $602,000
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $436,772 - $733,946	105,756 New	105,756 $453,000
Q1 2019 May 15, 2019	SELL	$2.0 - $4.4 $226,924 - $499,232	-113,462 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $182,673 - $410,732	113,462 New	113,462 $212,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account